MediPharm Strengthens Global Position in Q2 2025, with 14% Revenue Growth and 50% Increase in International Medical Cannabis

Q2 Revenue of $11.8 Million, an Increase of 14% over Q2 202450% Growth in Revenue for International Medical CannabisInternational Medical sales now 57% of Total RevenueCash Balance of$ 10.4 Million at the end of Q2, Increased from $8.4 Million in Q1 2025Management to Host Conference Call / Webcast on August 14th, 2025 at 10:00 am ET TORONTO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company"), a pharmaceutical company ...